The XAPRYLA brand, founded in 2006 (France), from 2757 sister brands and 17478 competing brands. The XAPRYLA brand is owned by SANOFI, a company listed in Paris. The ISIN, the company's International Securities Identification Number, is FR0000120578. XAPRYLA belongs to the Drug Manufacturers business sector.